Stem cells may be more widespread and with greater potential than previously believed

With the plethora of research and published studies on stem cells over the last decade, many would say that the definition of stem cells is well established and commonly agreed upon. However, a new review article appearing in the July 2014 issue of The FASEB Journal , suggests that scientists have only scratched the surface of understanding the nature, physiology and location of these cells. Specifically, the report suggests that embryonic and induced pluripotent stem cells may not be the only source from which all three germ layers in the human body (nerves, liver or heart and blood vessels) can develop. The review article suggests that adult pluripotent stem cells are located throughout the body and are able to become every tissue, provided these cells receive the right instructions.

"This study highlights the mutual role of stem cells both for regeneration and in tumor growth by featuring two sides of the same coin: stems cells in cancer and regenerative medicine," said Eckhard Alt, M.D., Ph.D., the article's lead author from the Center for Stem Cell and Developmental Biology at the University of Texas MD Anderson Cancer Center in Houston, Texas. "Our workprovides novel insight on why and how mature has provided us with one universal type of stem cell that is equally distributed throughout the whole body, every organ and every tissue. Small early are ubiquitously located in and around the throughout the whole body and serve as a reserve army for regeneration."

In the review, Alt and colleagues suggest that small early pluripotent stem cells are able to replace any kind of tissue in the body—independent of where they comes from in the body—given that these cells receive the correct instructions. When researchers extract these cells from fat tissue, concentrated them and then injected them into diseased or injured tissue, they delivered beneficial outcomes for ailments such as , osteoarthritis, non-healing wounds, soft tissue defects, muscle, bone and tendon injuries and neurodegenerative diseases. The review also discusses how this is basically the same process that occurs in tumors, except that instead of healing or regenerating tissue, the cells work toward building a tumor. Better understanding and manipulating how these cells communicate not only will open new therapies that heal injury (heart failure, wounds, etc.), but will allow researchers to stop many cancers before they become life-threatening.

"This article suggests that the countless hours spent researching cancer and are finally coming to a head," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "As the intersection between cancer and becomes closer and clearer, all of today's medical treatments will begin to look as crude as Civil War medicine."

More information: Matthias Ilmer, Jody Vykoukal, Alejandro Recio Boiles, Michael Coleman, and Eckhard Alt. Two sides of the same coin: stem cells in cancer and regenerative medicine. FASEB J. July 2014 28:2748-2761; DOI: 10.1096/fj.13-244640

add to favorites email to friend print save as pdf

Related Stories

A step closer to muscle regeneration

Dec 10, 2013

(Medical Xpress)—Muscle cell therapy to treat some degenerative diseases, including Muscular Dystrophy, could be a more realistic clinical possibility, now that scientists have found a way to isolate muscle cells from embryonic ...

Recommended for you

A novel therapy for sepsis?

7 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments